Home - ResourcesHigh-Cost Claims

Insights from the National Alliance 2025 high-cost claims coalition workshops, along with the latest research, highlight the urgent need for employers to embrace data-driven, collaborative, prevention-focused strategies to address cardiometabolic […]

Biosimilars are the future of specialty drug therapy, costing, on average, 50% less than their biological reference products, with some exceeding 90%. While adoption has been hindered by barriers such […]

 Biosimilars are the future of specialty drug therapy, costing, on average, 50% less than their biological reference products, with some exceeding 90%. While adoption has been hindered by barriers such […]

Pulse of the Purchaser, a national survey of employers, was conducted with member coalitions from July-August 2025 with 324 responses from private and public employers and purchasers across the country. […]

Action-oriented recommendations for coalitions, employers and other plan sponsors, and healthcare and benefits professionals.

Stay current with National Alliance

Get updates on health policy, delivery and payment reform, and whole person health trends sent directly to your inbox.